Performance of BRCA1/2 mutation prediction models in male breast cancer patients

S. Moghadasi, V. Grundeken, L. A. M. Janssen, N. H. Dijkstra, M. Rodriguez-Girondo, W. A. G. van Zelst-Stams, J. C. Oosterwijk, M. G. E. M. Ausems, R. A. Oldenburg, M. A. Adank, E. W. Blom, M. W. G. Ruijs, T. A. M. van Os, C. H. M. van Deurzen, J. W. M. Martens, C. P. Schroder, J. T. Wijnen, M. P. G. Vreeswijk, C. J. van Asperen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)52-59
Number of pages8
JournalClinical Genetics
Volume93
Issue number1
DOIs
Publication statusPublished - 1 Jan 2018

Keywords

  • BOADICEA
  • BRCA1
  • BRCA2
  • BRCAPRO
  • male breast cancer
  • Myriad prevalence table
  • RISK-ASSESSMENT MODEL
  • OVARIAN-CANCER
  • CARRIER PROBABILITIES
  • FAMILY-HISTORY
  • GENETIC SUSCEPTIBILITY
  • HEREDITARY BREAST
  • BOADICEA MODEL
  • CASE SERIES
  • VALIDATION

Cite this

Moghadasi, S., Grundeken, V., Janssen, L. A. M., Dijkstra, N. H., Rodriguez-Girondo, M., van Zelst-Stams, W. A. G., Oosterwijk, J. C., Ausems, M. G. E. M., Oldenburg, R. A., Adank, M. A., Blom, E. W., Ruijs, M. W. G., van Os, T. A. M., van Deurzen, C. H. M., Martens, J. W. M., Schroder, C. P., Wijnen, J. T., Vreeswijk, M. P. G., & van Asperen, C. J. (2018). Performance of BRCA1/2 mutation prediction models in male breast cancer patients. Clinical Genetics, 93(1), 52-59. https://doi.org/10.1111/cge.13065